|
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
RECRUITINGN/ASponsored by University of Illinois at Chicago
Actively Recruiting
PhaseN/A
SponsorUniversity of Illinois at Chicago
Started2021-04-01
Est. completion2025-05-31
Eligibility
Age21 Years – 75 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05208164
Summary
The proposed research and training will allow Dr. Alana Biggers to obtain critical research skills and study a mindfulness meditation program designed to improve sleep and reduce stress in African-American adults with diabetes. If effective, this program may reduce the risk of cardiovascular disease among African-Americans with type 2 diabetes who are at high risk of cardiovascular disease.
Eligibility
Age: 21 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria * Self-identifies as African American or Black * Diagnosis of type 2 diabetes * Valid address in greater Chicagoland area * Mobile phone with unlimited text-messaging * Mobile device (smartphone, tablet, or computer) with the ability to connect to the internet if remote online delivery * Availability to participate in mindfulness class either in-person or online * Age 21-75 Exclusion Criteria * Untreated obstructive sleep apnea (OSA) * Severe insomnia, narcolepsy, or REM sleep related disorder * Major cognitive impairments or psychiatric disorder * Alcohol or drug abuse * Limited English proficiency * Inability to send/receive text messages * Currently engaging in mindfulness practice
Conditions4
DiabetesSleepStressType 2 Diabetes
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Illinois at Chicago
Started2021-04-01
Est. completion2025-05-31
Eligibility
Age21 Years – 75 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05208164